(Q38021940)

27 August 2017

title

Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis (English)

1 reference

27 August 2017

1 reference

Sharawan Yadav

1

1 reference

27 August 2017

Anubhuti Dixit

2

1 reference

27 August 2017

Sonal Agrawal

3

1 reference

27 August 2017

Ashish Singh

4

1 reference

27 August 2017

Garima Srivastava

5

1 reference

27 August 2017

Anand Kumar Singh

6

1 reference

27 August 2017

Pramod Kumar Srivastava

7

1 reference

27 August 2017

Om Prakash

8

1 reference

27 August 2017

Mahendra Pratap Singh

9

1 reference

27 August 2017

publication date

27 June 2012

1 reference

27 August 2017

published in

Molecular Neurobiology

1 reference

27 August 2017

volume

46

1 reference

27 August 2017

issue

2

1 reference

27 August 2017

page(s)

495-512

1 reference

An Essay on the Shaking Palsy

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Charcot on Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Oxidative and inflammatory pathways in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Epidemiology and etiology of Parkinson's disease: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Parkinson's disease: clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Biomarkers in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: is it all set to irrefutable clinical translation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Effect of zinc and paraquat co-exposure on neurodegeneration: Modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Altered striatal dopamine release following a sub-acute exposure to manganese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Animal models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb- and paraquat-induced Parkinson's disease phenotype in mouse: mechanism of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Nigrostriatal proteomics of cypermethrin-induced dopaminergic neurodegeneration: microglial activation-dependent and -independent regulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Proteomics in Parkinson's disease: current trends, translational snags and future possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Tiny non-coding RNAs in Parkinson's disease: implications, expectations and hypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Gene-environment interactions: key to unraveling the mystery of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Functional genomic methodologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Functional genomics approaches to understanding brain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Synphilin suppresses α-synuclein neurotoxicity in a Parkinson's disease Drosophila model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Environmental-induced oxidative stress in neurodegenerative disorders and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Understanding the molecular causes of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Toxin-induced models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Pesticide exposure and risk for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Patterns of FOS expression in the spinal cord and periaqueductal grey matter of 6OHDA-lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Identification of bilateral changes in TID1 expression in the 6-OHDA rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Gene-environment interactions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Redox modification of Akt mediated by the dopaminergic neurotoxin MPTP, in mouse midbrain, leads to down-regulation of pAkt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

A tale on animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Response to "Paraquat: the red herring of Parkinson's disease research".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Carrier-mediated processes in blood--brain barrier penetration and neural uptake of paraquat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Cytotoxicity of paraquat in microglial cells: Involvement of PKCdelta- and ERK1/2-dependent NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Minocycline prevents paraquat-induced cell death through attenuating endoplasmic reticulum stress and mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Maneb potentiates paraquat neurotoxicity by inducing key Bcl-2 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

The effects of paraquat on regional brain neurotransmitter activity, hippocampal BDNF and behavioural function in female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Parkinson's disease risk from ambient exposure to pesticides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Matrix metalloproteinase-3 is activated by HtrA2/Omi in dopaminergic cells: relevance to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Animal models of Parkinson's disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Dopamine transporter genetic variants and pesticides in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Biochemical and toxicological evidence of neurological effects of pesticides: the example of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

A current review of cypermethrin-induced neurotoxicity and nigrostriatal dopaminergic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Organochlorine pesticides dieldrin and lindane induce cooperative toxicity in dopaminergic neurons: role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Iron accumulation in the substantia nigra of patients with Alzheimer disease and parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Advances in metal-induced oxidative stress and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: similarity with paraquat neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

The emerging science of BMAA: do cyanobacteria contribute to neurodegenerative disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Update on the genetics of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

The genetics of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Update on genetics of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Parkinson's disease: genetic versus toxin-induced rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Model fusion, the next phase in developing animal models for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

A dual-hit animal model for age-related parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Non-motor behavioural impairments in parkin-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Nonhuman primate models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Parkinson's disease: insights from non-traditional model organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Parkinson's disease mouse models in translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Modelling of Parkinson's disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Exploiting the potential of molecular profiling in Parkinson's disease: current practice and future probabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Microarrays in Parkinson's disease: a systematic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Association of GWAS loci with PD in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Common variants in PARK loci and related genes and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Gene expression profiles of mouse striatum in control and maneb + paraquat-induced Parkinson's disease phenotype: validation of differentially expressed energy metabolizing transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analyses of the striata in two mouse models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

The striatum is highly susceptible to mitochondrial oxidative phosphorylation dysfunctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Parkinson's disease: molecular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Protein deacetylation by SIRT1: an emerging key post-translational modification in metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Clinical proteomics: A need to define the field and to begin to set adequate standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Proteomics of human neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Neuroproteomics as a promising tool in Parkinson's disease research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Identification and quantification of protein posttranslational modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Proteomic approach to studying Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Understanding the molecular basis of Parkinson's disease, identification of biomarkers and routes to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Striatal 19S Rpt6 deficit is related to alpha-synuclein accumulation in MPTP-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Region-specific protein abundance changes in the brain of MPTP-induced Parkinson's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Proteomic analysis of expression and protein interactions in a 6-hydroxydopamine-induced rat brain lesion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Differential Proteome of the Striatum from Hemiparkinsonian Rats Displays Vivid Structural Remodeling Processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Biomarker discovery in neurodegenerative diseases: a proteomic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Blood-based proteomics for personalized medicine: examples from neurodegenerative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

A MicroRNA feedback circuit in midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

MicroRNAs (miRNAs) in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Alterations of the microRNA network cause neurodegenerative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Neurodegenerative diseases: pathology and the advantage of single-cell profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Molecular markers of early Parkinson's disease based on gene expression in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Proteomics in clinical interventions: achievements and limitations in biomarker development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Identification of differentially expressed proteins in striatum of maneb-and paraquat-induced Parkinson's disease phenotype in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Cationic lipids enhance siRNA-mediated interferon response in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-012-8291-8

Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway

21 January 2018

1 reference

12 December 2020

Toxin-induced and genetic animal models of Parkinson's disease

1 reference

12 December 2020

Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease.

1 reference

12 December 2020

Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease?

1 reference

12 December 2020

Transduced Tat-DJ-1 protein protects against oxidative stress-induced SH-SY5Y cell death and Parkinson disease in a mouse model

1 reference

12 December 2020

Blood proteome profiling in case controls and Parkinson's disease patients in Indian population

1 reference

12 December 2020

Buspirone improves haloperidol-induced Parkinson disease in mice through 5-HT(1A) recaptors

1 reference

12 December 2020

The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease

1 reference

12 December 2020

Glycoproteomics in neurodegenerative diseases

1 reference

12 December 2020

Toward identification of susceptibility genes for sporadic Parkinson's disease

1 reference

12 December 2020

Mechanisms to prevent caspase activation in rotenone-induced dopaminergic neurodegeneration: role of ATP depletion and procaspase-9 degradation

1 reference

12 December 2020

An essay on the shaking palsy. 1817.

1 reference

12 December 2020

The aetiology of idiopathic Parkinson's disease

1 reference

12 December 2020

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned model of parkinson's disease, with emphasis on mice and nonhuman primates.

1 reference

12 December 2020

2'-O-methyl-modified RNAs act as TLR7 antagonists

1 reference

12 December 2020

Amyloid P component as a plasma marker for Parkinson's disease identified by a proteomic approach

1 reference

12 December 2020

The role of transition metals in the pathogenesis of Parkinson's disease

1 reference

12 December 2020

CDNF protects the nigrostriatal dopamine system and promotes recovery after MPTP treatment in mice.

1 reference

12 December 2020

Limitations of animal models of Parkinson's disease

1 reference

12 December 2020

Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes

1 reference

12 December 2020

9-Methyl-beta-carboline has restorative effects in an animal model of Parkinson's disease

1 reference

12 December 2020

MPTP-induced model of Parkinson's disease in heat shock protein 70.1 knockout mice.

1 reference

12 December 2020

Surgical treatment of parkinsonism: indications and results

1 reference

12 December 2020

Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer

1 reference

12 December 2020

GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine.

1 reference

12 December 2020

Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease.

1 reference

12 December 2020

10.1007/S12035-012-8291-8

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1041548371

0 references

Fatcat ID

release_plaaqll2ard3rklpbcnl2usb64

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/plaaqll2ard3rklpbcnl2usb64

24 November 2022

mapped directly with Wikidata item

1 reference